Nexium 40 AstraZeneca: Compound Profile
Nexium 40 AstraZeneca is a pharmaceutical-grade esomeprazole preparation manufactured by AstraZeneca for research applications. Esomeprazole is a proton pump inhibitor compound that belongs to the benzimidazole class of gastric acid suppressants. This pharmaceutical compound is designed for in-vitro laboratory research examining gastroesophageal mechanisms and acid-related pathophysiology. Researchers at Stroid UK Shop can investigate this compound’s molecular interactions with gastric parietal cells and proton pump enzyme systems. The compound demonstrates selective inhibition of the hydrogen-potassium adenosine triphosphatase enzyme system, making it valuable for studying gastric acid production pathways in controlled laboratory environments.
Research Applications
Nexium 40 AstraZeneca serves as a reference standard for studying proton pump inhibition mechanisms in laboratory research. Scientists investigate this compound’s effects on gastric acid secretion pathways and its molecular interactions with parietal cell enzyme systems. Research applications include examining the compound’s pharmacokinetic properties, metabolic pathways through hepatic cytochrome P450 enzymes, and its selective binding characteristics to gastric hydrogen-potassium ATPase pumps. The preparation enables detailed analysis of acid suppression mechanisms and gastroesophageal physiology. Researchers studying esomeprazole compounds utilise this pharmaceutical-grade material for comparative studies alongside other research chemicals available through SARMs research and peptide investigations. Laboratory studies examine the compound’s stability profiles, degradation pathways, and molecular structure-activity relationships in controlled experimental conditions.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Esomeprazole 40mg |
| Manufacturer | AstraZeneca |
| Chemical Class | Proton Pump Inhibitor |
| Molecular Formula | Verify with supplier |
| CAS Number | Verify with supplier |
| Storage Requirements | Room temperature, dry conditions |
| Presentation | Pharmaceutical tablets |
| Research Grade | Pharmaceutical standard |
Research Compliance
Nexium 40 AstraZeneca is supplied exclusively for in-vitro laboratory research and analytical testing purposes. This pharmaceutical compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with all applicable laboratory safety protocols and regulatory requirements when handling this material. This product is designed for qualified research professionals conducting legitimate scientific investigations into proton pump inhibitor mechanisms and gastric physiology. All research applications must adhere to institutional guidelines and appropriate laboratory safety standards for pharmaceutical compound handling and storage.
